Nanotechnology offers innovative solutions for the early detection and diagnosis of CAD. Nanoparticles can be engineered to target specific biomarkers associated with atherosclerosis. For instance, quantum dots and gold nanoparticles can be used to enhance imaging techniques like MRI and CT scans, providing high-resolution images of arterial plaques. Additionally, nanobiosensors can detect minute changes in blood chemistry, offering a less invasive and more accurate diagnostic tool.
